Clinical Trial Update: A Study to Assess the Efficacy and Safety of Pagoclone for Adults With Stuttering [Phase 2, Phase 3]

View source ↗

Summary

The document provides a clinical trial update on pagoclone for adults with stuttering, covering Phase 2 and Phase 3 studies that have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stuttering

Drugs mentioned

• Pagoclone (pagoclone)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Stuttering | Phase 2, Phase 3 | Status: COMPLETED